Butrus Atrash

2.0k citations
39 papers · 1.2k indexed · h-index 18

Butrus Atrash

39 papers receiving 1.2k citations

Peers

Butrus Atrash
Comparison fields: 5 of 83
  • Oncology 323
  • Molecular Biology 767
  • Cell Biology 178
  • Organic Chemistry 260
  • Virology 39
Replace Hariprasad Vankayalapati with:
Hariprasad Vankayalapati United States
William D. Holmes United States
Veeraswamy Manne United States
Rashid Syed United States
Weihe Zhang United States
Joseph Rahuel Switzerland
Neil Moss United States
Tianbao Lu United States
Randall W. Hungate United States
Ted W. Johnson United States
Butrus Atrash relative to Hariprasad Vankayalapati United States Hariprasad Vankayalapati's profile →
Citations per field
00.5×5.6×
Hariprasad Vankayalapati · 1×
Citations per year

Countries citing papers authored by Butrus Atrash

Since Specialization
Citations

This map shows the geographic impact of Butrus Atrash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Butrus Atrash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Butrus Atrash more than expected).

Fields of papers citing papers by Butrus Atrash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Butrus Atrash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Butrus Atrash. The network helps show where Butrus Atrash may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Butrus Atrash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Butrus Atrash Line = papers co-authored together Butrus Atrash links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202064
2 20194
3 20164
4 201513
5 201290
6 201167
7 201126
8 201027
9 20103
10 200613
11 20069
12 200112
13 199510
14 199342
15 198782
16 19875
17
Renin inhibitors: their use in understanding the role of angiotensin II as a pressor hormone.
19854
18 198516
19 198320
20 1982183

About Butrus Atrash

Butrus Atrash is a scholar working on Cell Biology, Structural Biology and Oncology, having authored 39 papers that have together received 1.2k indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (12 papers), Chemical Synthesis and Analysis (11 papers), Cancer-related Molecular Pathways (6 papers), Peptidase Inhibition and Analysis (5 papers), Protein Degradation and Inhibitors (4 papers), Renin-Angiotensin System Studies (4 papers), Click Chemistry and Applications (3 papers) and Epigenetics and DNA Methylation (3 papers). The work is most often cited by research in Oncology (323 citations), Molecular Biology (767 citations) and Cell Biology (178 citations). Butrus Atrash has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Michael Szelke, Dylan M. Jones, Julian Blagg, B Leckie, A. Hallett, Anthony F. Lever, Vassilios Bavetsias, J.E. Sueiras, J.B. Cooper and Paul Workman. Their work appears in journals such as Nature, Angewandte Chemie International Edition and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026